Bandaram Pharma Packtech Q3FY26 Results Announced

Bandaram Pharma Packtech Limited announced Q3FY26 quarterly results for quarter and nine months ended 31.12.2025, showing mixed performance across standalone and consolidated operations.

Bandaram Pharma Packtech Board Changes Announced

Bandaram Pharma Packtech Limited announces appointment of Eswar Reddy Putturu as Additional Non-Executive Independent Director and resignation of Priyanka Agarwal from the Board effective 30.01.2026.

Bandaram Pharma Packtech Reports Loss of Rs. 34.74 Lakhs in Q2 FY26

Bandaram Pharma Packtech Limited posted a net loss of Rs. 34.74 lakhs for the quarter ended September 30, 2025, compared to a profit of Rs. 67.19 lakhs in the same quarter last year. The company's standalone revenue from operations declined significantly to Rs. 32.93 lakhs from Rs. 316.61 lakhs in the corresponding previous quarter.

Bandaram Pharma Packtech Promoters Acquire Additional Shares Through Preferential Allotment

Bandaram Pharma Packtech Limited disclosed a substantial acquisition of equity shares by its promoters and persons acting in concert. Prajitha Bandaram acquired 486,480 shares through preferential allotment on November 6, 2025. Following this acquisition, the promoter group's holdings include Prajitha Bandaram with 486,480 shares, Satyavathi Bandaram with 1,880,000 shares, B Premsai Reddy with 1,880,000 shares, and M. Seetharama Reddy with 112,500 shares. The company's equity share capital increased from Rs. 12 crores (1.2 crore shares of Rs. 10 each) to Rs. 17.97 crores (1.79 crore shares of Rs. 10 each) after the acquisition. The disclosure was filed under SEBI regulations for substantial acquisition of shares and takeovers.